KaiBiLi COVID-19 Antigen – koob candhuuf ah
Hordhac
The KaiBiLiTMCOVID-19 Qalabka Tijaabada Degdegga ah ee Antigen waa baaritaanka ogaanshaha in vitro ee ku saleysan mabda'a immunochromatography ee ogaanshaha tayada 2019 Novel Coronavirus nucleocapsid borotiinka antigens ee candhuufta.Baadhitaanku wuxuu ku salaysan yahay unugyada difaaca jirka kuwaas oo si gaar ah loo sameeyay aqoonsiga iyo falcelinta nukleoprotein-ka Novel Coronavirus 2019.Waxaa loogu talagalay in lagu caawiyo ogaanshaha degdegga ah ee caabuqa SARS-CoV-2.
COVID-19 waa cudur faafa oo neef-mareenka oo degdeg ah.Dadku guud ahaan waa u nugul yihiin.Hadda, bukaannada uu ku dhacay cudurka 'coronavirus' cusub ayaa ah isha ugu weyn ee caabuqa;Dadka cudurka asymptomatic-ka ah sidoo kale waxay noqon karaan il faafa.Iyada oo ku saleysan baaritaanka cudurrada faafa ee hadda, muddada soo-baxa waa 1 ilaa 14 maalmood, badiyaa 3 ilaa 7 maalmood.Calaamadaha ugu muhiimsan oo ay ku jiraan calaamadaha waxaa ka mid ah qandho, daal iyo qufac qallalan, sanka oo ciriiri ah, sanka duufsan, dhuun xanuun, myalgia iyo shuban ayaa laga helaa dhowr xaaladood.
Tilmaamaha & Faa'iidooyinka
The KaiBiLiTMTijaabada Degdegga ah ee Antigen-ka ee COVID-19 waa imtixaan-immunochromatographic ah oo lagu ogaanayo tayada 2019 Novel Coronavirus antigens.Qiimayntan waxaa loogu talagalay in si degdeg ah shaybaar loogu baaro.Imtixaankan waa inuu sameeyaa farsamo yaqaan tababaran, oo xidhan qalab ilaalin shaqsiyeed oo habboon (PPE).Tijaabada degdega ah ee Antigen-ka ee COVID-19 waxa uu leeyahay laba xaraf oo korka aaladda tijaabada ah oo tilmaamaya xariiqda tijaabada (T) iyo xariiqda xakamaynta (C).Khadka tijaabada iyo xariiqa kantaroolka ee daaqada natiijada lama arki karo ka hor inta aan la isticmaalin wax muunado ah.Xariiqda xakamaynta waa xariiq tixraaceed oo tilmaamaya in imtixaanku si sax ah u socdo.Khadka xakamaynta waa inuu soo baxaa mar kasta oo baaritaanka la sameeyo.Haddii SARS-CoV-2 uu ku jiro muunada, khadka tijaabada ayaa soo bixi doona.Unugyada difaaca jirka ee aadka loo xushay ee SARS-CoV-2 waxa loo adeegsadaa soo qabashada iyo baaraha baaritaanka.Unugyadan ayaa si toos ah u ogaan kara SARS-CoV-2 antigens, oo leh saxnaan sare.
Ogaanshaha
Ogaanshaha tayada leh ee 2019 Novel Coronavirus nucleocapsid borotiinka antigens ee candhuufta.
Tusaalooyinka
Candhuuf
Xadka ogaanshaha (LoD)
SARS-CoV-2: 140 TCID50/ml
Saxnaanta
Heshiiska boqolkiiba togan: 96.5%
Heshiiska Boqolkiiba Xun:97.8%
Guud ahaan Heshiska Boqolkiiba:97.2%
Waqtiga Natiijooyinka
Natiijooyinka ku akhri 15daqiiqo oo aan ka badnayn 30 daqiiqo.
Xaaladaha Kaydinta Kit
2 ~ 30°C.
Nuxurka
| Sharaxaada | Qty |
| Qalabka tijaabada ee COVID-19 antigen | 20 |
| Candhuufta aruuriya (koob iyo faruuryo) | 20 |
| Dhuumaha caagga ah | 20 |
| Tuubooyinka soo saarista (oo leh 0.5ml soo saarista) | 20 |
| Naaso leh shaandho | 20 |
| Tube Stand | 1 |
| Gelida Xidhmada | 1 |
Dalbashada Macluumaadka
| Alaabta | Bisad.Maya. | Nuxurka |
| KaiBiLiTMCOVID-19 Antigen | P211140-C | 20 imtixaan |
